Rx Plus will only source drugs from manufacturers that are registered with Health Canada and/or the FDA. Furthermore, previous history such as FDA warning letters, product recall history and active/inactive material procurement are taken into consideration. The majority of all generics selected by Rx Plus are shipped from the United Kingdom, Australia and New Zealand.

Rx Plus will not source generic drugs from manufacturers that have been cited by the FDA for violations pertaining to data integrity, falsification of records, sanitary conditions and failures to comply with Current Good Manufacturing Practices.

Rx Plus prides itself on being the only North American overseas distributor doing extensive due diligence in screening each and every drug manufacturer. As part of our commitment to transparency, we can provide customers with Health Canada and/or FDA registered manufacturing sites for each generic and brand name drug that is sold.

The bottom line, we are leading the way when it comes to patient safety and transparency.